Imiquimod.
Jobanputra
Kruti S
KS
Department of Dermatology, K. J. Somaiya Medical College and Hospital, Mumbai, Maharashtra, India. krutijobanputra@rediffmail.com
Rajpal
Aruna V
AV
Nagpur
N G
NG
D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000627:therapeutic use*; D000634:Aminoquinolines / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D000077271:Imiquimod; D012871:Skin Diseases / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D000077271:Imiquimod